Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-04
2006-07-04
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S341000, C544S333000, C546S275400
Reexamination Certificate
active
07071198
ABSTRACT:
A class of pyrazole derivatives is described for use in treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula IAwherein R1, R2, R3and R4are as described in the specification.
REFERENCES:
patent: 2004/0167197 (2004-08-01), Rudolph et al.
patent: 2003104223 (2003-12-01), None
Clare Michael
Collins Paul W.
Crich Joyce Zuowu
Devraj Rajesh
Flynn Daniel L.
Lappin Julie M.
Pharmacia Corporation
Solola Taofiq
LandOfFree
Substituted pyrazoles as p38 kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazoles as p38 kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazoles as p38 kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3610145